NanoNewron Awarded $2.5 Million in NIH STTR Phase 2 Grant to Advance its Innovative NN-840 Alzheimers Disease Program
The $2.5 Million in NIH STTR Phase 2 Grant allows NanoNewron to…
KFSHRC Conducts 48% of Clinical Trials in Saudi Arabia During the First Half of 2025
RIYADH, Saudi Arabia, Sept. 10, 2025 (GLOBE NEWSWIRE) -- King Faisal Specialist…
Aeluma Announces Fourth Quarter and Full Fiscal Year 2025 Financial Results
Momentum Building with New Contracts, Record Revenue, and Growing Interest Across Multiple…
AppFolio Ignites the Next Era of Real Estate at FUTURE 2025
SAN DIEGO, Sept. 09, 2025 (GLOBE NEWSWIRE) -- AppFolio (NASDAQ:APPF), the technology…
Chiesi Global Rare Diseases Highlights Continued Commitment to Rare Disease Community at the International Congress of Inborn Errors of Metabolism (ICIEM) 2025
September 09, 2025 11:00 ET Â | Source: Chiesi Global Rare Diseases Results…
KFSHRC Deputy CEO at C3 Davos of Healthcare Summit: AI Will Support, Not Replace, Healthcare Workers
NEW YORK, Sept. 09, 2025 (GLOBE NEWSWIRE) -- Artificial intelligence is ready…
Voxtur Announces Cease Trade Order and Notice of Default
September 08, 2025 19:18 ET Â | Source: Voxtur Analytics Corp. TORONTO and…
LEA Raises $1.25M to Power Client Data Automation Across the Wealth Management Industry
Social Leverage backs LEA’s mission to eliminate manual document work and quickly…
RadNet, Inc. to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference on Tuesday, September 9th, 2025
September 08, 2025 12:51 ET Â | Source: RadNet, Inc. LOS ANGELES, Sept.…
OSE Immunotherapeutics Provides Update on Ongoing Proceedings Ahead of Shareholders Annual General Meeting of September 30, 2025
OSE Immunotherapeutics Provides Update on Ongoing Proceedings Ahead of Shareholders’ Annual General…